KITLG and chronic kidney disease: This is the first study to record an association of SCF with progressive CKD, but considering increased mast cell activity has been observed in a range of kidney diseases [23,24,25,26,27,28,29,30,31], the SCF-progressive CKD association is perhaps unsurprising.